LR Health & Beauty SE, Europe's leading social commerce company for nutritional supplements and beauty products, has published its final annual report for 2025, confirming the preliminary sales and earnings figures. The company reported sales of EUR 277.1 million for the full year, down from EUR 289.2 million in 2024. Reported EBITDA stood at EUR 16.5 million, compared with EUR 27.3 million the previous year, impacted by one-off effects from the reorganization of its financing structure. Normalized EBITDA, which excludes these effects, amounted to EUR 22.5 million, versus EUR 32.6 million in 2024.
CEO Jörg Körfer commented on the results and the company's outlook: “The 2026 financial year is a transitional year for LR, during which we have laid the groundwork – both financially and strategically – for sustainable business growth and performance. The newly established financing structure gives us the momentum we need to continue to consistently pursue the initiatives we have launched in production, logistics and sales in the second half of the year. In this context, we are committed to working closely with our partners and are continuing to expand these relationships internationally.”
A key strategic pillar is expanding in-house production. LR is investing over 2 million euros in a new, high-performance production line, which will centralize the manufacture of the 5in1 product category entirely at its site in Ahlen. This includes established products such as LR 5in1 Beauty Elixir and LR 5in1 Men’s Shot. The new facility is designed to have an annual capacity of up to 40 million units and paves the way for further product innovations in the area of modern nutritional supplement concepts.
The full 2025 Annual Report is now available on the company’s website at https://ir.lrworld.com.
The LR Group, headquartered in Ahlen, Germany, produces and distributes high-quality nutritional supplements and cosmetic products in 32 countries. The company emphasizes personal consultation and digital solutions through its “LR neo” dashboard, which provides partners with all business-relevant key figures. Since 1985, LR has operated as a “people business,” appealing to those seeking flexibility, work-life balance, and financial independence. The company has over 20 years of expertise in aloe vera processing and operates one of Europe’s most modern aloe vera production facilities in Ahlen.
These strategic investments and the confirmed financial results underscore LR’s commitment to strengthening its operational capabilities and positioning for long-term growth. The new production line not only enhances efficiency but also supports product innovation, which could bolster the company’s competitive edge in the nutritional supplements market. The reorganization of the financing structure, despite its short-term impact on earnings, is intended to provide a solid foundation for future initiatives.
Stakeholders, including partners and investors, will likely view the published annual report as a transparent account of the company’s performance and strategic direction. The focus on in-house production and international expansion signals confidence in the demand for LR’s products and the resilience of its social commerce model.
